Prothena | Stammkapital





Stammkapital Veränderung Datum
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.28M 241K 2025-09
Akebia Therapeutics USD 2K 0 2025-03
ALKERMES USD 165.1M 49K 2025-09
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
Amgen USD 539M 1000K 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Exelixis USD 268.1M 2.03M 2025-09
Immunic USD 8K 4K 2024-06
Incyte USD 196.13M 2.01M 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
MacroGenics USD 63.26M 62.63M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
Prothena USD 53.83M 53.29M 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09
Xoma USD 87K 1000 2024-06


Prothena Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.